Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation

Journal of Cellular Physiology

Volumn 219, Issue 2, 2009, Pages 503-511

  Rotwein, Peter ^a   Wilson, Elizabeth M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD PROTEIN; PROTEIN KINASE B; PROTEIN KINASE B BETA; AKT1 PROTEIN, MOUSE; AKT2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL LEVEL; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME DEFICIENCY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SKELETAL MUSCLE; TISSUE DIFFERENTIATION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOLOGY; FIBROBLAST; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FIBROBLASTS; HUMANS; MICE; MUSCLE, SKELETAL; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 62149108988     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21692     Document Type: Article

References (50)

1. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. 2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019.
2. Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A, Zierath JR. 2006. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 4:89-96.
3. Brazil DP, Hemmings BA. 2001. Ten years of protein kinase B signalling: A hard Akt to follow. Trends Biochem Sci 26:657-664.
4. Brazil DP, Yang ZZ, Hemmings BA. 2004. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 29:233-242.
5. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EBr, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. 2001a. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728-1731.
6. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. 2001b. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349-38352.
7. Cleasby ME, Reinten TA, Cooney GJ, James DE, Kraegen EW. 2007. Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol 21:215-228.
8. Datta SR, Brunet A, Greenberg ME. 1999. Cellular survival: A play in three Akts. Genes Dev 13:2905-2927.
9. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, de Jong R, Oltersdorf T, Ludwig T, Efstratiadis A, Birnbaum MJ. 2005. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25:1869-1878.
10. Erbay E, Chen J. 2001. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J Biol Chem 276:36079-36082.
11. Fujio Y, Mitsuuchi Y, Testa JR, Walsh K. 2001. Activation of Akt2 Inhibits anoikis and apoptosis induced by myogenic differentiation. Cell Death Differ 8:1207-1212.
12. George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby AM, Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O'Rahilly S, Barroso I. 2004. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304:1325-1328.
13. Glass DJ. 2003. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5:87-90.
14. Gonzalez I, Tripathi G, Carter EJ, Cobb LJ, Salih DA, Lovett FA, Holding C, Pell JM. 2004. Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol 24:3607-3622.
15. Heron-Milhavet L, Franckhauser C, Rana V, Berthenet C, Fisher D, Hemmings BA, Fernandez A, Lamb NJ. 2006. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol 26:8267-8280.
16. Heron-Milhavet L, Mamaeva D, Rochat A, Lamb NJ, Fernandez A. 2008. Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA. J Cell Physiol 214:158-165.
17. Hoffman EP, Nader GA. 2004. Balancing muscle hypertrophy and atrophy. Nat Med 10:584-585.
18. Horsley V, Pavlath GK. 2004. Forming a multinucleated cell: Molecules that regulate myoblast fusion. Cells Tissues Organs 176:67-78.
19. Horsley V, Jansen KM, Mills ST, Pavlath GK. 2003. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113:483-494.
20. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, Natesan S, Brugge JS. 2005. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelialmesenchymal transition. J Cell Biol 171:1023-1034.
21. Jansen KM, Pavlath GK. 2006. Mannose receptor regulates myoblast motility and muscle growth. J Cell Biol 174:403-413.
22. Kaneko S, Feldman RI, Yu L, Wu Z, Gritsko T, Shelley SA, Nicosia SV, Nobori T, Cheng JQ. 2002. Positive feedback regulation between Akt2 and MyoD during muscle differentiation. Cloning of Akt2 promoter. J Biol Chem 277:23230-23235.
23. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ. 2004. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24:9295-9304.
24. Lawlor MA, Rotwein P. 2000. Insulin-like growth factor-mediated muscle cell survival: Central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol Cell Biol 20:8983-8995.
25. Lawlor MA, Feng X, Everding DR, Sieger K, Stewart CE, Rotwein P. 2000. Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol Cell Biol 20:3256-3265.
26. Liu H, Radisky DC, Nelson CM, Zhang H, Fata JE, Roth RA, Bissell MJ. 2006. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Natl Acad Sci USA 103:4134-4139.
27. Manning BD, Cantley LC. 2007. AKT/PKB signaling: Navigating downstream. Cell 129:1261-1274.
28. Nader GA. 2005. Molecular determinants of skeletal muscle mass: Getting the "AKT" together. Int J Biochem Cell Biol 37:1985-1996.
29. Nader GA. 2007. Muscle growth learns new tricks from an old dog. Nat Med 13:1016-1018.
30. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. 2002. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99:9213-9218.
31. Park IH, Chen J. 2005. Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. J Biol Chem 280:32009-32017.
32. Pelosi M, Marampon F, Zani BM, Prudente S, Perlas E, Caputo V, Cianetti L, Berno V, Narumiya S, Kang SW, Musaro A, Rosenthal N. 2007. ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program. Mol Cell Biol 27:6163-6176.
33. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17:1352-1365.
34. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ. 1999. Differentiation stage-specific inhibition of the Raf-MEKERK pathway by Akt. Science 286:1738-1741.
35. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3:1009-1013.
36. Sartorelli V, Fulco M. 2004. Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Sci STKE 2004:r11.
37. Stewart CE, Rotwein P. 1996. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 271:11330-11338.
38. Sugatani T, Hruska KA. 2005. Akt1/Akt2 andmammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280:3583-3589.
39. Thrash BR, Menges CW, Pierce RH, McCance DJ. 2006. AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J Biol Chem 281:12155-12162.
40. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P. 2001. Insulin-like growth factor-mediated muscle differentiation: Collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 276:39264-39270.
41. Vandromme M, Rochat A, Meier R, Carnac G, Besser D, Hemmings BA, Fernandez A, Lamb NJ. 2001. Protein kinase B beta/Akt2 plays a specific role in muscle differentiation. J Biol Chem 276:8173-8179.
42. Wilson EM, Rotwein P. 2006. Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281:29962-29971.
43. Wilson EM, Rotwein P. 2007. Selective control of skeletal muscle differentiation by Akt1. J Biol Chem 282:5106-5110.
44. Wilson EM, Hsieh MM, Rotwein P. 2003. Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J Biol Chem 278:41109-41113.
45. Wilson EM, Tureckova J, Rotwein P. 2004. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Mol Biol Cell 15:497-505.
46. Woodgett JR. 2005. Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 17:150-157.
47. Yaffe D, Saxel O. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270:725-727.
48. Yang ZZ, Tschopp O, Di-Poi N, Bruder E, Baudry A, Dummler B, Wahli W, Hemmings BA. 2005. Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/ PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice. Mol Cell Biol 25:10407-10418.
49. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. 2005. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20:539-550.
50. Zhou GL, Tucker DF, Bae SS, Bhatheja K, Birnbaum MJ, Field J. 2006. Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration. J Biol Chem 281:36443-36453.